Genetic testing should be offered to myeloma patients to identify high-risk cases earlier and enable more targeted and effective treatment, according to experts. A study by The Institute of Cancer ...
In certain cases, regulators will now be open to clearing therapies based on their ability to eliminate tumor cells, a change ...
Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces challenges in uptake and education. Multistakeholder partnerships and ...
Hosted on MSN
New research identifies more accurate way of predicting which blood cancer patients will relapse early
Findings support more comprehensive genetic testing They argue that the results support more comprehensive genetic testing at diagnosis to better guide treatment and disease monitoring of multiple ...
Treatment for stage 3 myeloma is typically divided into phases. The goal is to achieve a deep remission, meaning the cancer ...
Researchers at the Dana-Farber Cancer Institute in the US have unveiled a new blood test that could change the way multiple myeloma (MM) and its precursor conditions are diagnosed and monitored. The ...
Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new method, known ...
Multiple myeloma is a type of blood cancer that appears mainly after the age of sixty. Its incidence, therefore, increases with the aging of the population. In this pathology, the bone marrow, the ...
Boston, MA — Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new ...
Researchers from Mass General Brigham and the Broad Institute of MIT and Harvard have identified genetic modifications that can improve the efficacy of chimeric antigen receptor (CAR)-T cell treatment ...
Blood testing plays a critical role in both diagnosing and monitoring multiple myeloma. Patients often undergo a wide array of lab tests, which can initially be overwhelming. To simplify this, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results